Short Name | TargetExo-iRGD (Personalization) |
Description | Exosome surface modification of the targeting peptide iRGD. Integrin is the targeting receptor |
Technology Applications | Commonly used in the treatment of osteosarcoma, breast, ovarian, bladder, lung, liver, and colon cancers |
Storage | 2 °C to 8 °C |
Shelf-life | 2 years |
Structure |
Catalog: CDE23-001
Catalog: CDE23-002
Catalog: CDE23-003
Catalog: CDE23-004
Catalog: CDE23-005
Catalog: CDE23-006
Catalog: CDE23-007
Catalog: CDE23-008